| Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis K Boonstra, RK Weersma, KJ van Erpecum, EA Rauws, MBW Spanier, ... Hepatology 58 (6), 2045-2055, 2013 | 652 | 2013 |
| Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid EMM Kuiper, BE Hansen, RA de Vries, JW den Ouden–Muller, ... Gastroenterology 136 (4), 1281-1287, 2009 | 519 | 2009 |
| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ... Gastroenterology 147 (6), 1338-1349. e5, 2014 | 516 | 2014 |
| Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ... Gastroenterology 149 (7), 1804-1812. e4, 2015 | 444 | 2015 |
| Lysophosphatidic acid is a potential mediator of cholestatic pruritus AE Kremer, JJWW Martens, W Kulik, F Ruëff, EMM Kuiper, ... Gastroenterology 139 (3), 1008-1018. e1, 2010 | 438 | 2010 |
| High lifetime risk of cancer in primary sclerosing cholangitis MMH Claessen, FP Vleggaar, KMAJ Tytgat, PD Siersema, HR van Buuren Journal of hepatology 50 (1), 158-164, 2009 | 427 | 2009 |
| Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study F Wolfhagen, E Sternieri, W Hop, G Vitale, M Bertolotti, H van Buuren Gastroenterology 113 (4), 1264-1269, 1997 | 392 | 1997 |
| Genome-wide association study identifies variants associated with autoimmune hepatitis type 1 YS De Boer, NMF van Gerven, A Zwiers, BJ Verwer, B van Hoek, ... Gastroenterology 147 (2), 443-452. e5, 2014 | 332 | 2014 |
| Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions AE Kremer, R van Dijk, P Leckie, FG Schaap, EMM Kuiper, T Mettang, ... Hepatology 56 (4), 1391-1400, 2012 | 282 | 2012 |
| Sclerosing pancreato-cholangitis responsive to steroid therapy GW Erkelens, FP Vleggaar, W Lesterhuis, HR Van Buuren, ... The Lancet 354 (9172), 43-44, 1999 | 279 | 1999 |
| Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+ β‐blocker for prevention of variceal rebleeding IL Holster, ETTL Tjwa, A Moelker, A Wils, BE Hansen, JR Vermeijden, ... Hepatology 63 (2), 581-589, 2016 | 253 | 2016 |
| Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission NMF van Gerven, BJ Verwer, BI Witte, B van Hoek, MJ Coenraad, ... Journal of hepatology 58 (1), 141-147, 2013 | 247 | 2013 |
| Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands NMF van Gerven, BJ Verwer, BI Witte, KJ van Erpecum, HR van Buuren, ... Scandinavian journal of gastroenterology 49 (10), 1245-1254, 2014 | 229 | 2014 |
| High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis HR van Buuren, HJF van Hoogstraten, T Terkivatan, SW Schalm, ... Journal of hepatology 33 (4), 543-548, 2000 | 225 | 2000 |
| Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients PCJ Ter Borg, SW Schalm, BE Hansen, HR Van Buuren, ... Official journal of the American College of Gastroenterology| ACG 101 (9 …, 2006 | 217 | 2006 |
| Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis MH Harms, HR van Buuren, C Corpechot, D Thorburn, HLA Janssen, ... Journal of Hepatology 71 (2), 357-365, 2019 | 208 | 2019 |
| Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index C Merkel, M Zoli, S Siringo, H Van Buuren, D Magalotti, P Angeli, ... Official journal of the American College of Gastroenterology| ACG 95 (10 …, 2000 | 204 | 2000 |
| Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study PJ Trivedi, WJ Lammers, HR Van Buuren, A Parés, A Floreani, ... Gut 65 (2), 321-329, 2016 | 197 | 2016 |
| Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis K Boonstra, EL Culver, LM de Buy Wenniger, MJ van Heerde, ... Hepatology 59 (5), 1954-1963, 2014 | 191 | 2014 |
| Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome EMM Kuiper, PE Zondervan, HR Van Buuren Clinical gastroenterology and hepatology 8 (6), 530-534, 2010 | 173 | 2010 |
